PMV Pharmaceuticals PMVP Stock
PMV Pharmaceuticals Price Chart
PMV Pharmaceuticals PMVP Financial and Trading Overview
| PMV Pharmaceuticals stock price | 1.79 USD |
| Previous Close | 5.98 USD |
| Open | 5.88 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 5.87 - 6.46 USD |
| 52 Week Range | 3.84 - 17.78 USD |
| Volume | 328.32K USD |
| Avg. Volume | 466.88K USD |
| Market Cap | 287.01M USD |
| Beta (5Y Monthly) | 0.866215 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.44 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.5 USD |
PMVP Valuation Measures
| Enterprise Value | 57.78M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.0735295 |
| PEG Ratio (5 yr expected) | -0.13 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2470168 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.727 |
Trading Information
PMV Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.866215 |
| 52-Week Change | -40.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 17.78 USD |
| 52 Week Low | 3.84 USD |
| 50-Day Moving Average | 5.12 USD |
| 200-Day Moving Average | 8.35 USD |
PMVP Share Statistics
| Avg. Volume (3 month) | 466.88K USD |
| Avg. Daily Volume (10-Days) | 247.6K USD |
| Shares Outstanding | 45.78M |
| Float | 28.72M |
| Short Ratio | 25.06 |
| % Held by Insiders | 2.32% |
| % Held by Institutions | 125.35% |
| Shares Short | 6.56M |
| Short % of Float | 17.21% |
| Short % of Shares Outstanding | 14.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.55% |
| Return on Equity (ttm) | -28.35% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -79499000 USD |
| Net Income Avi to Common (ttm) | -74012000 USD |
| Diluted EPS (ttm) | -1.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 229.43M USD |
| Total Cash Per Share (mrq) | 5.01 USD |
| Total Debt (mrq) | 13.48M USD |
| Total Debt/Equity (mrq) | 5.86 USD |
| Current Ratio (mrq) | 22.028 |
| Book Value Per Share (mrq) | 5.028 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60774000 USD |
| Levered Free Cash Flow (ttm) | -45845124 USD |
Profile of PMV Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Cranbury |
| Address | 8 Clarke Drive |
| ZIP | 08512 |
| Phone | 609 642 6670 |
| Website | https://www.pmvpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 62 |
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations, including R273H, R273C, R175H, G245S, R248Q, and R282W, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
Q&A For PMV Pharmaceuticals Stock
What is a current PMVP stock price?
PMV Pharmaceuticals PMVP stock price today per share is 1.79 USD.
How to purchase PMV Pharmaceuticals stock?
You can buy PMVP shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PMV Pharmaceuticals?
The stock symbol or ticker of PMV Pharmaceuticals is PMVP.
Which industry does the PMV Pharmaceuticals company belong to?
The PMV Pharmaceuticals industry is Biotechnology.
How many shares does PMV Pharmaceuticals have in circulation?
The max supply of PMV Pharmaceuticals shares is 51.44M.
What is PMV Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
PMV Pharmaceuticals PE Ratio is now.
What was PMV Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
PMV Pharmaceuticals EPS is -1.44 USD over the trailing 12 months.
Which sector does the PMV Pharmaceuticals company belong to?
The PMV Pharmaceuticals sector is Healthcare.
PMV Pharmaceuticals PMVP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}